Related Experiment Video

Updated: Aug 22, 2025

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

17.5K

Engineering a pure and stable heterodimeric IgA for the development of multispecific therapeutics

Florian Heinkel1, Meghan M Verstraete1, Siran Cao1

  • 1Zymeworks Inc., Vancouver, BC, Canada.

Mabs
|November 7, 2022
PubMed
Abstract

Keywords:
Fc engineeringIgA therapeuticsantibody engineeringantibody stabilitybiophysical characterization of antibodybispecific antibodyheterodimeric antibodymultivalent scaffoldquality by design

More Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.5K
Generation of Murine Monoclonal Antibodies by Hybridoma Technology09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

42.1K

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.2K